Blog
12-23-2025Cross-posted from ClinicalinfoThe Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV (Pediatric…
NIH
Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV - Blog
Update to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection 11-24-2025Editor’s Note: This news item was originally published by Clinicalinfo on September 30, 2025. HIV.gov is cross-posting it now to share these important updates… - Blog
Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV 09-26-2025The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and… - Blog
Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV 07-16-2025The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated.Cytomegalovirus… - Blog
Update to the Perinatal HIV Clinical Guideline 06-17-2025The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission has updated the Recommendations for the Use of Antiretroviral Drugs… - Blog
Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV 06-11-2025The Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV (Pediatric Opportunistic Infection Guidelines)… - Blog
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox 03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox… - Blog
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain 12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild… - Blog
Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV 11-20-2024The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated. Highlights from the updated… - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients with HIV (HIV R+) was safe and comparable to… - Blog
Updates to the Guidance for People With HIV Displaced by Disasters 10-16-2024The Guidance for People With HIV Displaced by Disasters, which was last updated in 2018, provides guidance to health care providers attending to the medical… - Blog
Defining the Goals of HIV Science Through 2034 10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical research enterprise. For more information, please… - Blog
Dr. Geri Donenberg Named NIH Associate Director for AIDS Research 09-19-2024Cross-posted from: NIH Office of the Director I am pleased to announce the selection of Geri R. Donenberg, Ph.D., as NIH Associate Director for AIDS Research… - Blog
ICYMI: Research Roundup from AIDS 2024 08-15-2024A brief roundup of key topics of HIV.gov’s coverage of AIDS 2024, including HIV prevention, cure research, and more. - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID NewsroomCurrent or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse… - Blog
Supporting Research for Older Adults Living with HIV 06-10-2024Cross-posted from: Inside NIA Blog During the early years of the AIDS epidemic four decades ago, life expectancy for a person diagnosed with HIV was just three… - Blog
FYI Video: A Conversation About the Importance of HIV Vaccine Research 06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH’s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for… - Blog
NIAID Marks HIV Vaccine Awareness Day 2024 05-17-2024Cross-posted from: NIAID NowVaccines consistently transform public health, and HIV vaccine research has been a pillar of NIAID’s scientific mission since the… - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can… - Blog
NIH Ending the HIV Epidemic Projects Bridge Gaps Between HIV Research and Public Health Practice (VIDEO) 04-09-2024Cross-posted from: NIAID Now Blog The National Institutes of Health recently issued $26M in awards to HIV research institutions in its fifth year supporting…